Cargando…
Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD – subgroup analysis of the Taiwan obstructive lung disease cohort
BACKGROUND AND OBJECTIVE: The overprescription of inhaled corticosteroids (ICS) in the current Global Initiative for Chronic Obstructive Lung Disease (GOLD) group A and B patients with chronic obstructive pulmonary disease (COPD) is not uncommon in clinical practice. The aim of this study was to exp...
Autores principales: | Wei, Yu-Feng, Kuo, Ping-Hung, Tsai, Ying-Huang, Tao, Chi-Wei, Cheng, Shih-Lung, Lee, Chao-Hsien, Wu, Yao-Kuang, Chen, Ning-Hung, Hsu, Wu-Huei, Hsu, Jeng-Yuan, Lin, Ming-Shian, Wang, Chin-Chou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574850/ https://www.ncbi.nlm.nih.gov/pubmed/26392770 http://dx.doi.org/10.2147/COPD.S88114 |
Ejemplares similares
-
The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study
por: Hsieh, Meng-Jer, et al.
Publicado: (2018) -
Wheezing, a significant clinical phenotype of COPD: experience from the Taiwan Obstructive Lung Disease Study
por: Huang, Wan-Chun, et al.
Publicado: (2015) -
Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
por: Cheng, Shih-Lung, et al.
Publicado: (2017) -
“Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD
por: Vogelmeier, Claus, et al.
Publicado: (2017) -
Impact of overweight and obesity on acute exacerbations of COPD – subgroup analysis of the Taiwan Obstructive Lung Disease cohort
por: Wei, Yu-Feng, et al.
Publicado: (2017)